We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Dutch company Akzo Nobel announced Aug. 15 that it will call a general meeting of its shareholders to vote on whether to spin off Organon, the firm’s pharmaceutical business.